Intralesional Treatment of Established Murine Primary Renal Tumor With Interleukin-4: Localized Effect on Primary Tumor With no Impact on Metastases
- 1 February 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (2) , 490-493
- https://doi.org/10.1097/00005392-199502000-00068
Abstract
In an effort to develop new strategies for immunotherapy of metastatic renal cell carcinoma, we investigated the therapeutic potential of interleukin-4 in a visceral renal tumor using the m...Keywords
This publication has 12 references indexed in Scilit:
- Immunotherapy of renal cell carcinomaCA: A Cancer Journal for Clinicians, 1993
- The skin immune system: progress in cutaneous biologyImmunology Today, 1993
- Interleukin-4 and Cancer TherapyCancer Investigation, 1993
- Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.Journal of Clinical Investigation, 1993
- Synergy of Radiation Therapy and Immunotherapy in Murine Renal Cell CarcinomaJournal of Urology, 1992
- Adoptive immunotherapy of cancer: biological response modifiers and cytotoxic cell therapyBiotherapy, 1992
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4Science, 1991
- Cancer metastasisBritish Medical Bulletin, 1991
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989